Long-term antibiotic prophylaxis reduces mortality in people with advanced liver disease

A multicenter, randomized, controlled study presented today found that long-term oral antibiotic therapy with norfloxacin improved the prognosis of people with life-threatening advanced liver disease. The study, presented at The International Liver Congress™ 2017 in Amsterdam, The Netherlands, showed that norfloxacin administration for six months was associated with a reduced risk of death and infection at six months in patients with Child-Pugh class C cirrhosis, a very severe and advanced stage of liver disease. …read more

Source: EurekAlert

(Visited 3 times, 1 visits today)

Popular Posts